Supplement: Barbara Schilberg

Barbara Schilberg By Anne Harding A champion for the region DUSTIN FENSTERMACHER / WONDERFUL MACHINE RELATED ARTICLES A Region Defined Did You Know? A Rich Life Science Cluster Greater Philadelphia's Big Pharmas A Robust Support Infrastructure Bridging the Gap Brenda Gavin: Making a venture capitalist Investment Momentum Building Update Those Resumes Creating Roots Ramping Up Tech Transfer When Barbara Schilberg was wrapping up her

Written byAnne Harding
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A Region Defined

Did You Know?

A Rich Life Science Cluster

Greater Philadelphia's Big Pharmas

A Robust Support Infrastructure

Bridging the Gap

Brenda Gavin: Making a venture capitalist

Investment Momentum Building

Update Those Resumes

Creating Roots

Ramping Up Tech Transfer

When Barbara Schilberg was wrapping up her fourth job in senior management at a biotech company and looking for her next opportunity, she made a discovery that she says shocked her. "I realized there weren't that many small startup companies in the region, and it was a shame because I had all this great experience."

As Shilberg cast about in vain for a new generation of life science startups, she heard of an opportunity to help create one. Pennsylvania was using $33.8 million from its tobacco settlement to set up a "greenhouse" for supporting biotech businesses in the southeastern part of the state. So in 2002 Schilberg was named ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies